Michael Kitt - Net Worth and Insider Trading

Michael Kitt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Kitt owns 2 companies in total, including Portola Pharmaceuticals Inc (PTLA) , and Innoviva Inc (INVA) .

Click here to see the complete history of Michael Kitt’s form 4 insider trades.

Insider Ownership Summary of Michael Kitt

Ticker Comapny Transaction Date Type of Owner
PTLA Portola Pharmaceuticals Inc 2013-05-21 Senior VP and CMO
INVA Innoviva Inc 2004-10-04 Sr. Vice President Development

Michael Kitt Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael Kitt Ownership Network

Ownership Network List of Michael Kitt

No Data

Ownership Network Relation of Michael Kitt

Insider Network Chart

Michael Kitt Owned Company Details

What does Portola Pharmaceuticals Inc do?

Who are the key executives at Portola Pharmaceuticals Inc?

Michael Kitt is the Senior VP and CMO of Portola Pharmaceuticals Inc. Other key executives at Portola Pharmaceuticals Inc include EVP & General Counsel John B Moriarty , EVP and CFO Mardi Dier , and EVP & CMO Rajiv Patni .

Portola Pharmaceuticals Inc (PTLA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Portola Pharmaceuticals Inc (PTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Portola Pharmaceuticals Inc (PTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Portola Pharmaceuticals Inc (PTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Portola Pharmaceuticals Inc Insider Transactions

No Available Data

Michael Kitt Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Kitt. You might contact Michael Kitt via mailing address: 901 Gateway Boulevard, South San Francisco Ca 94080.

Discussions on Michael Kitt

No discussions yet.